Biotechnology Focus, a compendium of the Canadian life sciences industry, has published the following guest column by Dr. Raphael Hofstein, MaRS Innovation’s president & CEO, and Elizabeth Monier-Williams, director of marketing and communications.
There’s a historical trend in Canadian culture with far-reaching effects for the way we do business, ranging from entertainment to academia to science. Namely, it’s that until quite recently, Canadians weren’t into cultivating national star systems. [1]
As Gideon Hayden recently wrote for TechCrunch, if you’re a Canadian tall poppy ...
June 7, 2016
in Encycle Therapeutics, Government Partners, Industry Partners, Media Coverage, News, Partnerships, Sunnybrook Health Sciences Centre, Triphase Accelerator Corporation, University of Toronto, Vasomune Therapeutics Inc.
Read more